Ogkologos

4396 ΔΗΜΟΣΙΕΥΣΕΙΣ 0 ΣΧΟΛΙΑ

What Comes after NCI-MATCH? NCI’s New Precision Medicine Cancer Trials

Ogkologos - 6 Δεκεμβρίου, 2023

Sotorasib in Combination with Panitumumab Results in Longer PFS in Patients...

Ogkologos - 6 Δεκεμβρίου, 2023

How Joining a Clinical Trial Helped Me Find Hope While Living...

Ogkologos - 5 Δεκεμβρίου, 2023

Neoadjuvant Toripalimab Combined with Axitinib Demonstrates a Promising Pathologic Response Rate...

Ogkologos - 5 Δεκεμβρίου, 2023

First Study to Demonstrate that PD1 Immune Checkpoint Blockade May Yield...

Ogkologos - 4 Δεκεμβρίου, 2023

Tarlatamab Shows Promise for Some People with Small Cell Lung Cancer

Ogkologos - 1 Δεκεμβρίου, 2023

EMA Recommends Extending Indications for Pembrolizumab to Patients with Advanced Biliary...

Ogkologos - 1 Δεκεμβρίου, 2023

Learning to Live With Cancer: A Survivor’s Story

Ogkologos - 30 Νοεμβρίου, 2023

Groundbreaking Trial Results Expand Treatment Options for Some People with Bladder...

Ogkologos - 30 Νοεμβρίου, 2023

FDA Amends Indication for Pembrolizumab in the First-Line Treatment for Patients...

Ogkologos - 30 Νοεμβρίου, 2023

1...100101102...440 Σελίδα 101 από 440

MOST POPULAR

Researchers Find New, Effective Tools to Determine Breast Cancer Risk Using...

29 Δεκεμβρίου, 2020

What Are Drug Shortages and How Can They Impact Care for...

23 Ιουνίου, 2023

Study Provides Closer Look at Postmenopausal Bleeding and Endometrial Cancer

29 Αυγούστου, 2018

Activity of Alectinib for ALK-Rearranged Metastatic Solid Tumours, Other Than NSCLC

19 Απριλίου, 2022

Φόρτωση περισσοτέρων

What Comes after NCI-MATCH? NCI’s New Precision Medicine Cancer Trials

Sotorasib in Combination with Panitumumab Results in Longer PFS in Patients...

How Joining a Clinical Trial Helped Me Find Hope While Living...

Neoadjuvant Toripalimab Combined with Axitinib Demonstrates a Promising Pathologic Response Rate...

First Study to Demonstrate that PD1 Immune Checkpoint Blockade May Yield...

Tarlatamab Shows Promise for Some People with Small Cell Lung Cancer

EMA Recommends Extending Indications for Pembrolizumab to Patients with Advanced Biliary...

Learning to Live With Cancer: A Survivor’s Story

Groundbreaking Trial Results Expand Treatment Options for Some People with Bladder...

FDA Amends Indication for Pembrolizumab in the First-Line Treatment for Patients...

MOST POPULAR

Researchers Find New, Effective Tools to Determine Breast Cancer Risk Using...

What Are Drug Shortages and How Can They Impact Care for...

Study Provides Closer Look at Postmenopausal Bleeding and Endometrial Cancer

Activity of Alectinib for ALK-Rearranged Metastatic Solid Tumours, Other Than NSCLC

HOT NEWS

Radionuclide Therapy Could Be A Viable Treatment For Early-Stage Breast Cancer,...

EMA Recommends Granting a Marketing Authorisation for Lisocabtagene Maraleucel

Pembrolizumab Demonstrates Robust, Durable Antitumour Activity and Promising Survival in Advanced...

NCI Launches New Resource for Specimens and Data from Cancer Clinical...

ΔΗΜΟΦΙΛΕΊΣ ΘΈΣΕΙΣ

ΚΑΡΚΙΝΟΣ ΘΥΜΟΥ ΑΔΕΝΑ (ΘΥΜΩΜΑ)

ΣΤΑΤΙΣΤΙΚΑ

ΚΕΝΤΡΙΚΟΥ ΝΕΥΡΙΚΟΥ ΣΥΣΤΗΜΑΤΟΣ

ΔΗΜΟΦΙΛΗ ΚΑΤΗΓΟΡΙΑ